ArticleEuropean journal of rheumatology2022
Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm.
Akash Gupta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.